MEUD 📈 Amundi Stoxx Europe 600 - Overview

Exchange: PA • Country: France • Currency: EUR • Type: Etf • ISIN: LU0908500753 • Europe Large-Cap Blend Equity

MEUD: European, Stocks, Bonds

The Amundi Stoxx Europe 600 UCITS ETF C, traded under the ticker MEUD on the Paris stock exchange, is a financial instrument designed to track the performance of the Stoxx Europe 600 index. This index is a broad representation of the European stock market, covering approximately 600 stocks from 18 European countries, providing a comprehensive overview of the region's equity market. The fund is domiciled in Luxembourg, a well-established hub for investment funds due to its favorable regulatory environment and tax efficiency.

As an Exchange-Traded Fund (ETF), the Amundi Stoxx Europe 600 UCITS ETF C offers investors the flexibility to buy and sell shares throughout the trading day, similar to stocks. It falls under the category of Europe Large-Cap Blend Equity, indicating that it invests in a mix of large-cap stocks from European companies, aiming to balance growth and value investing strategies. The ISIN code LU0908500753 is used to identify this specific fund internationally, facilitating cross-border transactions and regulatory compliance. The fund's underlying index, while not explicitly mentioned as being the Morningstar DM Eur TME NR EUR in this context, typically would be designed to capture the performance of the European developed market, excluding smaller caps and focusing on the more liquid and established companies.

For investors seeking broad exposure to the European large-cap market, the Amundi Stoxx Europe 600 UCITS ETF C can serve as a core holding in a portfolio. It provides diversification benefits by covering a wide range of sectors and countries, potentially reducing risk through its diversified portfolio. The fund's structure as a UCITS (Undertakings for the Collective Investment in Transferable Securities) compliant ETF ensures that it adheres to strict European regulatory standards, enhancing transparency and investor protection. The company behind the fund, Amundi, is one of the largest asset managers in Europe, offering a range of investment solutions, including this ETF, which can be found on their website at https://first-eagle.amundi.com/.

Additional Sources for MEUD ETF

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

MEUD ETF Overview

Market Cap in USD 9,083m
Category Europe Large-Cap Blend Equity
TER 0.07%
IPO / Inception 2024-02-08

MEUD ETF Ratings

Growth 5y 57.2%
Fundamental -
Dividend -
Rel. Strength Industry 133
Analysts -
Fair Price Momentum 217.82 EUR
Fair Price DCF -

MEUD Dividends

No Dividends Paid

MEUD Growth Ratios

Growth Correlation 3m -43.7%
Growth Correlation 12m 68.4%
Growth Correlation 5y 88.8%
CAGR 5y 6.53%
CAGR/Mean DD 5y 1.05
Sharpe Ratio 12m 0.39
Alpha -11.71
Beta 0.67
Volatility 14.52%
Current Volume 4k
Average Volume 20d 60.5k
What is the price of MEUD stocks?
As of December 27, 2024, the stock is trading at EUR 235.20 with a total of 4,041 shares traded.
Over the past week, the price has changed by -0.76%, over one month by -0.42%, over three months by -3.88% and over the past year by +7.99%.
Is Amundi Stoxx Europe 600 a good stock to buy?
Partly, yes. Based on ValueRay Analyses, Amundi Stoxx Europe 600 (PA:MEUD) is currently (December 2024) ok to buy, but has to be watched. It has a Growth Technical Rating of 57.22 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MEUD as of December 2024 is 217.82. This means that MEUD is currently overvalued and has a potential downside of -7.39%.
Is MEUD a buy, sell or hold?
Amundi Stoxx Europe 600 has no consensus analysts rating.
What are the forecast for MEUD stock price target?
According to ValueRays Forecast Model, MEUD Amundi Stoxx Europe 600 will be worth about 239.7 in December 2025. The stock is currently trading at 235.20. This means that the stock has a potential upside of +1.9%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 239.7 1.9%